ArticleClinical pharmacology and therapeutics2018

Risk-Benefit Assessment of Ethinylestradiol Using a Physiologically Based Pharmacokinetic Modeling Approach.

Udoamaka Ezuruike et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.